100 Companies in Contract Pharmaceutical Research – White Paper

    Published: March 27, 2018 | Price: $0.00

    This brief White Paper lists over one hundred companies that are involved in drug discovery in one form or another.  A company website and address is provided for each company.  The White Paper does not detail companies or discuss the CRO marketplace - for this purpose, please consult our recent report, Outsourcing in Drug Discovery, 8th Edition.
    Bill Payment

    Published: February 26, 2019 | Price:

    Cell and Gene Therapy Business Outlook

    Published: January 1, 2022 | Price:

    How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions.  It can be a daunting task to keep up.  Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore.  Now from Science and Medicine...
    Emerging Infectious Disease Market Trends, 2022

    Published: August 22, 2022 | Price: $0.00 – $10,000.00

    The search for the next large-scale emerging disease was on before the COVID-19 pandemic.  Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat.  The search is constant, and is by no means limited to respiratory epidemics.  As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats.  This necessitates the development of tests at laboratories.  For business planners, it’s worthwhile to have a...
    The Market for Contract Manufacturing in In Vitro Diagnostics (IVD)

    Published: September 2, 2022 | Price: $0.00 – $12,000.00

    The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...
    The Market for RNA Sequencing, 2nd Edition

    Published: September 7, 2022 | Price: $0.00 – $9,000.00

    The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.  Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...
    Medical Device Tax: Will There Be a R&D Effect?

    Published: September 13, 2013 | Price: $50.00 – $100.00

    The medical device tax that took effect Jan. 1, 2013 for all manufacturers of Class I, Class II and Class III devices in the United States may have had an impact on device company spending, according to this complimentary Public Policy Paper from Kalorama Information.  While the tax was in effect in the 2012 year, the paper looks at budgeted R&D spending as companies anticipated new costs from the program. The conclusions are the result of information from Kalorama Information's...
    IVD Trends Spring 2018

    Published: June 7, 2018 | Price: $99.00 – $198.00

    A summary of major trends in the IVD industry, from harmonization to Cardiac marker testing.
    Sample Preparation and Library Preparation for DNA Sequencers (Results of The Kalorama Survey of Labs)

    Published: January 1, 2011 | Price: $150.00 – $300.00

    Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama's biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as sample preparation, cycle sequencing and sequencing reaction cleanup with capillary systems. The report's perspective is demand-side, focusing on what labs are doing today. The information...
    The Market for Rx to OTC Switches, 5th Edition

    Published: February 1, 2011 | Price: $150.00 – $300.00

    While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over-the-counter status where possible. In the early part of the last decade there was a decline in Rx-to-OTC switches; since 2006, however, there has been a number of uses of this tactic to extend the revenue of pharmaceutical products. In Kalorama Information's Market for...
    US Market for Picture Archiving Systems (PACS), The

    Published: February 1, 2011 | Price: $150.00 – $300.00

    This report covers the U.S. market for Picture Archiving and Communication Systems (PACS) and provides an overview of imaging systems, EMR and PACS technologies and products. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report addresses some of the issues surrounding IT in healthcare and how the PACS arena is affected by these issues. While Kalorama Information has studied EMR markets in great detail in other reports, this report does...
    Virtual Reality (VR) in Healthcare in the U.S. (Markets for Surgery, Visualization, Rehabilitation and Training)

    Published: February 1, 2011 | Price: $150.00 – $300.00

    What are virtual reality technologies and how are they being used in healthcare today? What areas of healthcare are seeing the most use of these products? What is the expected market opportunity for companies entering the market for VR equipment? Who are the main players in the VR market and what moves are they making to grow market share? These are among the questions answered in Kalorama Information's Virtual Reality in Healthcare in the U.S. The use of virtual reality...
    World Market for Molecular Diagnostics, 4th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas): Potential and Reality, What’s Hot and What’s Not, The

    Published: March 1, 2011 | Price: $150.00 – $300.00

    This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not estimates the market for molecular diagnostics and provides a realistic look at the role of molecular testing and its future in various market segments. Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA, also reviews the competitors in the market and their latest moves. There have been many predictions made about a molecular revolution in diagnostics. Indeed some are now taking place, while other...
    EMR 2011: The Market for Electronic Medical Record Systems

    Published: March 1, 2011 | Price: $150.00 – $300.00

    For several years Kalorama Information has been studying the trend of electronic medical records (EMR) and electronic health records (EHR). What was already a fast-growing market dramatically changed in 2009 when as part of the ARRA stimulus law, the US Government provided incentives for physicians and hospitals to use systems. Those incentives have now been clarified and in 2011, the first checks have been issued. What will be the impact of those incentives, as well as vendor actions? And what...
    Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia

    Published: March 25, 2011 | Price: $150.00 – $300.00

    The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets. The population of nearly 4 billion people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn't stopped companies from investing in Asian vaccine markets. The graying of the population in Asia and the growth in some regions...